Clinical Trials in Baltimore

Showing 3641-3660 of 11,213 trials

Safety and Suitability of Supplementing Early MIP Surgery (MIPS) of ICH With Pioglitazone

NCT05582707

This is an exploratory single-center prospective study of 20 subjects with primary basal ganglia ICH who will receive early MIPS in combination with perioperative pioglitazone treatment. Outcomes will be compared to matched subjects with basal ganglia ICH who undergo MIPS alone as part of the ENRICH trial. This study will take approximately two years to complete.

Intracerebral Haemorrhage, Intraventricular

University of Maryland, Baltimore1 participantsStarted May 2023

Baltimore, Maryland, United States

COMPLETED< 1 mile

A Study to Characterize the Outcomes of Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt Ovarian Cancer

NCT05775549

This study will collect the data from existing patient medical records at US cancer centers. The study will include patients with BRCAwt ovarian cancer who have been prescribed first line (1L) olaparib maintenance treatment.

Advanced Ovarian Cancer

AstraZeneca24 participantsStarted Jul 2023

Tampa, Florida, United States • Shreveport, Louisiana, United States • Annapolis, Maryland, United States +4 more locations

COMPLETEDPhase 2< 1 mile

Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML Patients

NCT01838395

A study is designed to assess if BL-8040 in combination with cytarabine (Ara-C) can help controlling the disease in patients with Acute Myeloid Leukemia (AML) that have relapsed or did not respond adequately to previous treatment. The safety of the study drug combination will also be studied.

Acute Myeloid Leukemia

BioLineRx, Ltd.42 participantsStarted Apr 2013

Jacksonville, Florida, United States • Baltimore, Maryland, United States • St Louis, Missouri, United States +7 more locations

Safety and Suitability of Supplementing Early MIP Surgery (MIPS) of ICH With Pioglitazone

A Study to Characterize the Outcomes of Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt Ovarian Cancer

Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML Patients

Find Trials by Condition in Baltimore

Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma

A Study to Assess the Safety of SAB-176 to Prevent the Flu, Given IM in Healthy Adults Compared With Placebo

Magnetic Resonance Imaging (MRI) Ofl Volunteers

Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis

Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors

A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine

Prostate Imaging Using MRI +/- Contrast Enhancement

Viz HCM (ECG Assist) Utilization Workflow Pilot

A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers

Air Optix® Night and Day® Aqua Continuous Wear

An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051 (Vesleteplirsen)

A Randomized Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1

Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers

Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND1 Mutations

A Study to Evaluate the Efficacy, Safety, and Concentration of SNS812 in Mild to Moderate COVID-19 Patients

Target Controlled Infusion Using Propofol and Remifentanil for Moderate Sedation in Dentistry